Navigation Links
Experimental Dengue Vaccine Shows Some Success
Date:9/11/2012

TUESDAY, Sept. 11 (HealthDay News) -- An experimental vaccine may offer protection from dengue fever, a potentially fatal mosquito-borne illness, according to a new study.

The vaccine was safe and effective against three of the four viruses that cause the disease, researchers found in the study, published online Sept. 10 in The Lancet.

Dengue fever occurs in tropical and subtropical areas, according to the World Health Organization. The number of cases has increased significantly in recent years, and in 2009 the disease made a return to the continental United States.

According to the Florida Department of Health, in 2009, 27 people living in Key West came down with illness via locally acquired infections, and then 66 more residents contracted the illness in 2010. The outbreak seems to have eased since then, however.

Dengue symptoms typically appear three days to two weeks after a mosquito bite and can range from mild to incapacitating fever with severe headache, pain behind the eyes, muscle and joint pain, and rash. Severe dengue, which mostly occurs in children, includes fever, abdominal pain, vomiting and bleeding.

"Nearly half a million people are thought to be hospitalized with dengue every year, the majority of which are children, so the development of a safe and effective vaccine has the potential to make a hugely positive impact," study co-author Dr. Derek Wallace of Sanofi Pasteur, the company that developed the vaccine, said in a journal news release.

In conducting the study, researchers in France and Thailand tested the effectiveness of the possible vaccine known as CYD-TDV, on more than 4,000 Thai children ranging in age from 4 to 11 years. Of these children, 2,669 were given the vaccine, while the others received an inactive placebo.

The study found 2.8 percent of the children who received the vaccine were diagnosed with dengue, compared with 4.4 percent among the placebo group. This was not a statistically significant difference.

However, secondary tests revealed the vaccine was effective in protecting against three of the viruses that cause dengue, DENV 1, 3 and 4, the researchers say. The virus DENV 2 was resistant to the vaccine. None of the children who received the vaccine suffered serious side effects, according to the report.

Although the trial was limited to Thailand, the researchers say their findings advance the development of a dengue vaccine.

"Our study constitutes the first-ever demonstration that a safe and effective dengue vaccine is possible," Wallace said. "Further trials of CYD-TDV are currently under way in a number of different countries, and our hope is that the positive results of this trial will be confirmed by these larger studies, taking place in a wide range of epidemiological settings."

Developing a vaccine for dengue has been slowed by the fact that it is caused by four different viruses, the release noted. Moreover, because dengue is also believed to be unique to humans, scientists cannot test the vaccine on animal models.

In an accompanying journal commentary, Dr. Scott Halstead, of the International Vaccine Institute in Seoul, South Korea, said that future dengue vaccine trials should determine if the vaccine is effective against severe and mild forms of the disease.

More information

The U.S. Centers for Disease Control and Prevention has more about dengue.

-- Mary Elizabeth Dallas

SOURCE: The Lancet, news release, Sept. 10, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Standard chemotherapy provides higher survival rate than experimental in lung cancer patients
2. Cancer turns off important immune cells, complicating experimental vaccine therapies
3. Experimental Drug May Cut Severe Asthma Attacks: Study
4. Experimental Drug Suppresses Appetite in Mice: Study
5. Experimental Chemical Helps Blind Mice See
6. Experimental drug may extend therapeutic window for stroke
7. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
8. Content Writing King Announces Cancellation Of Experimental Video Creation Process For Their Article Marketing Website
9. Experimental Vaccine Seems to Stop Nicotine Addiction in Mice
10. Experimental drug improves muscle strength among male cancer patients
11. Experimental Drug Helps Fight Some Childhood Cancers, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experimental Dengue Vaccine Shows Some Success
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... 24, 2016 , ... People across the U.S. are sharpening their pencils and ... essay contest in which patients and their families pay tribute to a genetic counselor ... National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... VIEW, Calif. , June 23, 2016 ... a.m. CST on Thursday, July 7, 2016 , , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  , ... Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa ... The global pharmaceutical industry is witnessing an ...
(Date:6/23/2016)... June 23, 2016 Revolutionary technology ... Oticon , industry leaders in advanced audiology and ... Oticon Opn ™, the world,s first internet connected ... for IoT devices.      (Photo: http://photos.prnewswire.com/prnh/20160622/382240 ... a number of ,world firsts,: , TwinLink™ ...
Breaking Medicine Technology: